The groundbreaking success of Sildenafil undeniably transformed the medication landscape, but betting in companies heavily reliant on generic versions presents a complex picture. Although early profits were impressive, the end of patents and the appearance of less expensive alternatives have weakened sales. Therefore, a thorough assessment of curre